SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS‐CoV‐2–host interactomes and provided great resources for understanding viral replication. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaonan, Huuskonen, Sini, Laitinen, Tuomo, Redchuk, Taras, Bogacheva, Mariia, Salokas, Kari, Pöhner, Ina, Öhman, Tiina, Tonduru, Arun Kumar, Hassinen, Antti, Gawriyski, Lisa, Keskitalo, Salla, Vartiainen, Maria K, Pietiäinen, Vilja, Poso, Antti, Varjosalo, Markku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552907/
https://www.ncbi.nlm.nih.gov/pubmed/34709727
http://dx.doi.org/10.15252/msb.202110396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552907/
https://www.ncbi.nlm.nih.gov/pubmed/34709727
http://dx.doi.org/10.15252/msb.202110396

Ejemplares similares